Abstract: Systems and methods are disclosed in which ammonia may be recovered efficiently from wastewater through the application of the mass-transfer reaction kinetic model. The recovery process may involve the stripping of NH3 from wastewater by aeration and the absorption of this stripped NH3 gas into a recovery solution by utilizing stoichiometric acid-base reactions and the operating parameters optimized by the model which facilitate both processes. Another step may be performed in which saturated solution comprising the recovered NH3 may be further evaporated and liquefy to produce a pure bioammonia product. Applying the mass-transfer reaction kinetic to the recovery can not only enhance the NH3 removal and recovery yield but also increase the NH3 removal and recovery rate. Numerous operating parameters can be adjusted to maximize the recovery yield and recovery rate.

Abstract: Spiral chute (1), adapted to convey an object from an inlet (I) to an outlet (O) downwards along a sliding area (S) in a sliding manner, wherein the sliding area (S) defines a spiral conveying direction (D); the spiral chute (1) comprises a plurality of steps (6), which are arranged along the spiral conveying direction (D), each of the steps having a sliding face (62) for vertically supporting the sliding objects; wherein the spiral chute is adapted so that an inclination angle (i) of the sliding face (62) relative to the horizontal plane can selectively be adapted.

Abstract: A consumable item dispenser and method may include an ingredient storage unit configured to store a consumable ingredient used to produce consumable items by the dispenser. A sensor may be configured to sense an amount of consumable ingredient remaining to be dispensed. An input/output unit may be configured to communicate data over a communications network. A processing unit may be in communication with the sensor, and be configured to authenticate an electronic device associated with an operator and register the electronic device associated with the operator. A determination as to whether an amount of the ingredient in the ingredient storage unit is at or below a threshold level. The processing unit may generate a notification indicative that the ingredient is at or below a threshold level, and communicate the notification to the operator in response to being generated.

Abstract: A system and method for creating a mixed consumable item may include displaying a first set of selectable indicia on a touchscreen, where the indicia may be (i) indicative of respective consumable ingredients and (ii) distinctly positioned relative to one another. A swype gesture may be received from a user via the touchscreen that forms a path extending between a first position and a second position that touches or passes close to multiple selectable indicia. From the first set of consumable ingredients, a plurality of combinations of consumable ingredients most likely to have been intended to be selected by the user based on the path of the swype gesture may be predicted. Selectable predicted combinations of consumable ingredients may be displayed on the touchscreen to enable one of the selectable combinations of consumable ingredients to be selected by the user for mixing by a dispenser of consumable items.

Abstract: One embodiment may include a machine for providing beverages. The machine may include a reader configured to read data representative of an available balance for a user to obtain beverages from the machine from a machine-readable medium and electronics. The electronics may be configured to receive the data from the machine-readable medium in response to the user positioning the machine-readable medium within reading distance of the reader, enable the user to dispense a beverage into a vessel, and update the available balance of the machine-readable medium so as to reduce or prevent the user from dispensing unlimited beverages.

Abstract: The present invention is directed to heteroarylpiperidine ether compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

Abstract: A consumable item dispenser and method may include an ingredient storage unit configured to store a consumable ingredient used to produce consumable items by the dispenser. A sensor may be configured to sense an amount of consumable ingredient remaining to be dispensed. An input/output unit may be configured to communicate data over a communications network. A processing unit may be in communication with the sensor, and be configured to authenticate an electronic device associated with an operator and register the electronic device associated with the operator. A determination as to whether an amount of the ingredient in the ingredient storage unit is at or below a threshold level. The processing unit may generate a notification indicative that the ingredient is at or below a threshold level, and communicate the notification to the operator in response to being generated.

Abstract: A consumable item dispenser and method may include an ingredient storage unit configured to store a consumable ingredient used to produce consumable items by the dispenser. A sensor may be configured to sense an amount of consumable ingredient remaining to be dispensed. An input/output unit may be configured to communicate data over a communications network. A processing unit may be in communication with the sensor, and be configured to authenticate an electronic device associated with an operator and register the electronic device associated with the operator. A determination as to whether an amount of the ingredient in the ingredient storage unit is at or below a threshold level. The processing unit may generate a notification indicative that the ingredient is at or below a threshold level, and communicate the notification to the operator in response to being generated.

Abstract: One embodiment may include a machine for providing beverages. The machine may include a reader configured to read data representative of an available balance for a user to obtain beverages from the machine from a machine-readable medium and electronics. The electronics may be configured to receive the data from the machine-readable medium in response to the user positioning the machine-readable medium within reading distance of the reader, enable the user to dispense a beverage into a vessel, and update the available balance of the machine-readable medium so as to reduce or prevent the user from dispensing unlimited beverages.

Abstract: A consumable item dispenser and method may include an ingredient storage unit configured to store a consumable ingredient used to produce consumable items by the dispenser. A sensor may be configured to sense an amount of consumable ingredient remaining to be dispensed. An input/output unit may be configured to communicate data over a communications network. A processing unit may be in communication with the sensor, and be configured to authenticate an electronic device associated with an operator and register the electronic device associated with the operator. A determination as to whether an amount of the ingredient in the ingredient storage unit is at or below a threshold level. The processing unit may generate a notification indicative that the ingredient is at or below a threshold level, and communicate the notification to the operator in response to being generated.

Abstract: Systems and methods for collecting and processing livestock waste to facilitate the reclamation of water used in such processes and likewise produce fertilizer/soil amendments. Animal waste is initially collected, mixed with water and sequentially processed whereby large fibers present in the waste are separated, and the resultant manure sludge effluent. The manure sludge effluent may be treated with ultrasound, enzymatic pretreatment, aeration and/or polymers to promote coagulation and flocculation. A solids separation step is then performed to facilitate the separation of water and isolation of solids, the latter of which are formed into manure cakes and ultimately fertilizer/soil amendment products. The separated water is purified for reuse while further generating a nutrient concentrate.

Abstract: The present invention is directed to heteroarylpiperidine ether compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

Abstract: A system and method for creating a mixed consumable item may include displaying a first set of selectable indicia on a touchscreen, where the indicia may be (i) indicative of respective consumable ingredients and (ii) distinctly positioned relative to one another. A swype gesture may be received from a user via the touchscreen that forms a path extending between a first position and a second position that touches or passes close to multiple selectable indicia. From the first set of consumable ingredients, a plurality of combinations of consumable ingredients most likely to have been intended to be selected by the user based on the path of the swype gesture may be predicted. Selectable predicted combinations of consumable ingredients may be displayed on the touchscreen to enable one of the selectable combinations of consumable ingredients to be selected by the user for mixing by a dispenser of consumable items.

Abstract: The present invention relates to novel amyloid binding compounds of formula (I) and methods for measuring effects of the compounds, by measuring changes of amyloid plaque level in living patients. More specifically, the present invention relates to a method of using the compounds of this invention as tracers in positron emission tomography (PET/) imaging to study amyloid deposits in brain in vivo to allow diagnosis of Alzheimer's disease. Thus, the present invention relates to use of the novel amyloid binding compounds as a diagnostic. The invention further relates to a method of measuring clinical efficacy of Alzheimer's disease therapeutic agents. Specifically, the present invention relates to novel aryl or heteroaryl substituted azabenzoxazole derivatives, compositions, and therapeutic uses and processes for making such compounds, or a pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof, wherein: X is O or S; A and Y independently are N, or CH.

Abstract: The present invention relates to novel amyloid binding compounds of formula (I) and methods for measuring effects of the compounds, by measuring changes of amyloid plaque level in living patients. More specifically, the present invention relates to a method of using the compounds of this invention as tracers in positron emission tomography (PET/) imaging to study amyloid deposits in brain in vivo to allow diagnosis of Alzheimer's disease. Thus, the present invention relates to use of the novel amyloid binding compounds as a diagnostic. The invention further relates to a method of measuring clinical efficacy of Alzheimer's disease therapeutic agents.

Abstract: The present invention relates to novel amyloid binding compounds and methods for measuring effects of the compounds, by measuring changes of amyloid plaque level in living patients. More specifically, the present invention relates to a method of using the compounds of this invention as tracers in positron emission tomography (PET) imaging to study amyloid deposits in brain in vivo to allow diagnosis of Alzheimer's disease. Thus, the present invention relates to use of the novel amyloid binding compounds as a diagnostic. The invention further relates to a method of measuring clinical efficacy of Alzheimer's disease therapeutic agents. Specifically, the present invention relates to novel aryl or heteroaryl substituted pyrazole derivatives, compositions, and therapeutic uses and processes for making such compounds.

Abstract: The present invention relates to novel amyloid binding compounds and methods for measuring effects of the compounds, by measuring changes of amyloid plaque level in living patients. More specifically, the present invention relates to a method of using the compounds of this invention as tracers in positron emission tomography (PET) imaging to study amyloid deposits in brain in vivo to allow diagnosis of Alzheimer's disease. Thus, the present invention relates to use of the novel amyloid binding compounds as a diagnostic. The invention further relates to a method of measuring clinical efficacy of Alzheimer's disease therapeutic agents. Specifically, the present invention relates to novel aryl or heteroaryl substituted indole derivatives, compositions, and therapeutic uses and processes for making such compounds.